|1.||Vas, Adám: 1 article (11/2005)|
|2.||Gulyás, Balázs: 1 article (11/2005)|
|3.||Sharma, Rajendra K: 1 article (10/2005)|
|4.||Das, Shankar B: 1 article (10/2005)|
|5.||Lupi, F: 1 article (10/2004)|
|6.||Barile, L: 1 article (10/2004)|
|7.||Messina, E: 1 article (10/2004)|
|8.||Giacomello, A: 1 article (10/2004)|
11/01/2005 - "Since its introduction to the market as a neuroprotective agent many non clinical and clinical studies proved vinpocetine's effects on calmodulin dependent phosphodiesterase E1, on sodium, calcium channels, peripheral benzodiazepine receptor, and glutamate receptors as well as its clinical usefulness in the treatment of post-ischaemic stroke disease states and various disorders of cerebrovascular origin. "
10/01/2004 - "We have also investigated the effects of some specific inhibitors of phosphodiesterases (PDE1, PDE3, PDE4 and PDE5) on human neuroblastoma (LAN5 and SHEP) growth and differentiation. "
05/01/1989 - "Expression of calmodulin-dependent phosphodiesterase, calmodulin-dependent protein phosphatase, and other calmodulin-binding proteins in human SMS-KCNR neuroblastoma cells."
|3.||Brain Neoplasms (Brain Tumor)
|1.||Glutamate Receptors (Glutamate Receptor)
|2.||Calcium Channels (Calcium Channel)
|4.||GABA-A Receptors (GABA(A) Receptor)
|6.||Calmodulin-Binding Proteins (Caldesmon)
|7.||Calmodulin (Calcium-Dependent Activator Protein)